2017-03-15,UniQure Announces 2016 Financial Results And Provides Update On Company Progress
2017-03-03,UniQure Receives 2017 Frost & Sullivan Manufacturing Leadership Award
2017-03-01,UniQure Announces Presentations At Upcoming March Conferences
2017-02-06,UniQure Announces Presentations At Upcoming February Conferences
2017-01-30,UniQure Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B
2017-01-25,UniQure Appoints Alexander Kuta As Senior Vice President Of Regulatory Affairs
2017-01-09,UniQure Outlines Key Initiatives For 2017 And Vision For 2018
2017-01-06,5 Stocks Setting Up for Big Breakouts
2016-12-19,UniQure Appoints Matthew Kapusta As Chief Executive Officer
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-03,UniQure Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B
2016-12-03,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
2016-12-02,UniQure To Present At The Genetic Rx Boston Biotech Conference At Harvard Medical School
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-15,UniQure Completes Strategic Review To Refocus Its Pipeline, Reduce Operating Costs And Deliver Long-Term Shareholder Value
2016-09-26,UniQure To Present At The Jefferies Gene Editing And Gene Therapy Summit In New York City
2016-09-22,UniQure Announces Management And Board Changes
2016-09-16,UniQure Receives NASDAQ Deficiency Letter Related To Board Composition
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-17,UniQure To Present At Upcoming Investor Conferences In September
2016-07-29,8 Stocks Under $10 to Trade for Huge Profits
2016-07-27,UniQure Presents Updated Clinical Data In Patients With Severe Hemophilia B Demonstrating Up To 9 Months Of Sustained Levels Of Factor IX Activity And Therapeutic Effect
2016-07-11,UniQure Announces Oral Presentation Of Updated Results For AMT-060 At The World Federation Of Hemophilia (WFH) 2016 World Congress
2016-07-07,UniQure Appoints Jonathan Garen As Chief Business Officer
2016-07-01,These 5 Stocks Are Ready for Breakouts
2016-06-27,UniQure Appoints Maria E. Cantor As Senior Vice President, Investor Relations & Communications
2016-06-14,Trade-Ideas: UniQure (QURE) Is Today's Weak On High Relative Volume Stock
2016-06-11,UniQure Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity
2016-05-31,UniQure Announces Results For First Quarter 2016
2016-05-19,UniQure Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association
2016-05-12,UniQure To Present At Upcoming Investor Conferences In New York City
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT
2016-05-03,UniQure Appoints Paul Firuta As Chief Commercial Officer
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-04,CORRECTING And REPLACING -- UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-04-04,UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-03-24,Interesting QURE Put And Call Options For May 20th
2016-03-22,UniQure Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease
2016-03-14,UniQure Announces Dosing Of First Patient In High-Dose Cohort In Phase I/II Hemophilia B Clinical Trial
2016-03-02,UniQure To Present At The 36th Cowen & Company Health Care Conference
2016-02-15,UniQure To Present At The RBC Capital Markets 2016 Global Healthcare Conference
2016-01-28,'Mad Money' Lightning Round: Take the Money and Run From Sprint
2016-01-27,Jim Cramer's 'Mad Money' Recap: More Pain Ahead, Thanks to the Fed
2016-01-11,UniQure (QURE) Weak On High Volume Today
2016-01-08,Buy These 5 Breakout Stocks Now for Big Gains
2016-01-07,UniQure Announces Preliminary Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2016-01-06,UniQure Announces Conference Call And Webcast To Discuss Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2015-12-18,UniQure Appoints Dan Soland As Chief Executive Officer
2015-12-14,UniQure Added To NASDAQ Biotechnology Index
2015-11-30,UniQure (QURE) Weak On High Volume Today
2015-11-30,UniQure Announces Financial Results For Third Quarter 2015 And Provides Update On Product Pipeline And Company Developments
2015-11-23,UniQure Announces Conference Call And Webcast To Discuss Third Quarter Financial Results And Corporate Update
2015-11-12,UniQure To Present At The Jefferies 2015 Global Healthcare Conference - London
2015-11-06,Interesting QURE Put And Call Options For November 20th
2015-10-07,UniQure To Host Investor Day In New York City On October 15, 2015
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-09-30,UniQure (QURE) Marked As A Dead Cat Bounce Stock
2015-09-22,Today's Dead Cat Bounce Stock: UniQure (QURE)
2015-09-21,UniQure (QURE) Trading With Heavy Volume Before Market Open
2015-09-19,Positive Topline Results Announced From Phase I/II Trial In Sanfilippo B Syndrome Patients Using UniQure's Novel AAV5-Based Gene Therapy
2015-09-18,UniQure (QURE) Is Today's Strong On High Volume Stock
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-01,UniQure To Present At NewsMakers In The Biotech Industry Conference - NYC
2015-08-27,UniQure Announces Financial Results For Second Quarter 2015
2015-08-10,UniQure Announces Receipt Of $53 Million From Bristol-Myers Squibb For Target Selection Payment And Additional Equity Investment
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-07-16,Dr. Charles W. Richard Joins UniQure As Senior Vice President To Lead Development Of CNS-focused Gene Therapy Pipeline
2015-06-13,Bluebird Sickle Cell Gene Therapy Results Keep Getting Better
2015-06-11,UniQure Announces Financial Results For First Quarter 2015
2015-05-27,UniQure To Present At The Jefferies 2015 Healthcare Conference
2015-05-26,UniQure Announces Closing Of Strategic Collaboration With Bristol-Myers Squibb To Develop Gene Therapies For Cardiovascular Disease
2015-05-21,Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease
2015-05-12,Ratings Changes Today
2015-04-26,Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
2015-04-15,UniQure Announces Closing Of Follow-on Public Offering
2015-04-09,UniQure Announces Pricing Of Follow-on Public Offering
2015-04-07,UniQure Announces Launch Of Follow-on Public Offering
2015-04-06,Market News: Tesla Motors Inc, Uniqure NV, Transocean LTD
2015-04-06,Stocks Spike on Fed Rate Hike Speculation; Microsoft Leads Dow
2015-04-06,Stocks Drive Higher as Energy Rally Overshadows Weak Jobs Report
2015-04-06,UniQure NV (QURE) Stock Soars to 52-Week High on Bristol-Myers Squibb Investment
2015-04-06,UniQure Announces Webcast To Discuss Bristol-Myers Squibb Collaboration
2015-04-06,UniQure Announces Results For Fourth Quarter And Financial Year 2014
2015-04-06,Bristol-Myers Squibb And UniQure Enter Into Exclusive Strategic Collaboration To Develop Gene Therapies For Cardiovascular Diseases
2015-02-23,UniQure To Present At The At The Cowen And Company 35th Annual Health Care Conference
2015-02-06,UniQure To Present At The At The Leerink Partners Global Healthcare Conference
2015-01-15,Gold Surge Spells Good Things For Soros, Dalio
2015-01-14,Treeway Announces License And Collaboration Agreement With UniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS)
2015-01-09,UniQure Appoints Matthew Kapusta As Chief Financial Officer
2015-01-05,Ackman Short Keeps Looking Better As Herbalife Takes A Dive
2014-12-05,UniQure To Present At The Oppenheimer 25th Healthcare Conference - NYC
2014-12-01,UniQure Announces Results For The Third Quarter Of 2014
2014-11-21,UniQure To Host Investor Day In New York City
2014-11-10,UniQure To Present At Jefferies Global Healthcare Conference - London
2014-10-27,AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data From Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate
2014-09-25,UniQure To Present At The Leerink Partners Rare Disease Roundtable Conference
2014-09-02,UniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs
2014-08-11,UniQure Acquires Cardiology Gene Therapy Company InoCard
2014-08-04,Chiesi And UniQure Provide Update On Glybera(r) Launch
2014-04-28,3 Stocks Rising on Big Volume
,
,
2017-03-15,UniQure Announces 2016 Financial Results And Provides Update On Company Progress
2017-03-03,UniQure Receives 2017 Frost & Sullivan Manufacturing Leadership Award
2017-03-01,UniQure Announces Presentations At Upcoming March Conferences
2017-02-06,UniQure Announces Presentations At Upcoming February Conferences
2017-01-30,UniQure Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B
2017-01-25,UniQure Appoints Alexander Kuta As Senior Vice President Of Regulatory Affairs
2017-01-09,UniQure Outlines Key Initiatives For 2017 And Vision For 2018
2017-01-06,5 Stocks Setting Up for Big Breakouts
2016-12-19,UniQure Appoints Matthew Kapusta As Chief Executive Officer
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-03,UniQure Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B
2016-12-03,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
2016-12-02,UniQure To Present At The Genetic Rx Boston Biotech Conference At Harvard Medical School
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-15,UniQure Completes Strategic Review To Refocus Its Pipeline, Reduce Operating Costs And Deliver Long-Term Shareholder Value
2016-09-26,UniQure To Present At The Jefferies Gene Editing And Gene Therapy Summit In New York City
2016-09-22,UniQure Announces Management And Board Changes
2016-09-16,UniQure Receives NASDAQ Deficiency Letter Related To Board Composition
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-17,UniQure To Present At Upcoming Investor Conferences In September
2016-07-29,8 Stocks Under $10 to Trade for Huge Profits
2016-07-27,UniQure Presents Updated Clinical Data In Patients With Severe Hemophilia B Demonstrating Up To 9 Months Of Sustained Levels Of Factor IX Activity And Therapeutic Effect
2016-07-11,UniQure Announces Oral Presentation Of Updated Results For AMT-060 At The World Federation Of Hemophilia (WFH) 2016 World Congress
2016-07-07,UniQure Appoints Jonathan Garen As Chief Business Officer
2016-07-01,These 5 Stocks Are Ready for Breakouts
2016-06-27,UniQure Appoints Maria E. Cantor As Senior Vice President, Investor Relations & Communications
2016-06-14,Trade-Ideas: UniQure (QURE) Is Today's Weak On High Relative Volume Stock
2016-06-11,UniQure Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity
2016-05-31,UniQure Announces Results For First Quarter 2016
2016-05-19,UniQure Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association
2016-05-12,UniQure To Present At Upcoming Investor Conferences In New York City
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT
2016-05-03,UniQure Appoints Paul Firuta As Chief Commercial Officer
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-04,CORRECTING And REPLACING -- UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-04-04,UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-03-24,Interesting QURE Put And Call Options For May 20th
2016-03-22,UniQure Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease
2016-03-14,UniQure Announces Dosing Of First Patient In High-Dose Cohort In Phase I/II Hemophilia B Clinical Trial
2016-03-02,UniQure To Present At The 36th Cowen & Company Health Care Conference
2016-02-15,UniQure To Present At The RBC Capital Markets 2016 Global Healthcare Conference
2016-01-28,'Mad Money' Lightning Round: Take the Money and Run From Sprint
2016-01-27,Jim Cramer's 'Mad Money' Recap: More Pain Ahead, Thanks to the Fed
2016-01-11,UniQure (QURE) Weak On High Volume Today
2016-01-08,Buy These 5 Breakout Stocks Now for Big Gains
2016-01-07,UniQure Announces Preliminary Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2016-01-06,UniQure Announces Conference Call And Webcast To Discuss Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2015-12-18,UniQure Appoints Dan Soland As Chief Executive Officer
2015-12-14,UniQure Added To NASDAQ Biotechnology Index
2015-11-30,UniQure (QURE) Weak On High Volume Today
2015-11-30,UniQure Announces Financial Results For Third Quarter 2015 And Provides Update On Product Pipeline And Company Developments
2015-11-23,UniQure Announces Conference Call And Webcast To Discuss Third Quarter Financial Results And Corporate Update
2015-11-12,UniQure To Present At The Jefferies 2015 Global Healthcare Conference - London
2015-11-06,Interesting QURE Put And Call Options For November 20th
2015-10-07,UniQure To Host Investor Day In New York City On October 15, 2015
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-09-30,UniQure (QURE) Marked As A Dead Cat Bounce Stock
2015-09-22,Today's Dead Cat Bounce Stock: UniQure (QURE)
2015-09-21,UniQure (QURE) Trading With Heavy Volume Before Market Open
2015-09-19,Positive Topline Results Announced From Phase I/II Trial In Sanfilippo B Syndrome Patients Using UniQure's Novel AAV5-Based Gene Therapy
2015-09-18,UniQure (QURE) Is Today's Strong On High Volume Stock
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-01,UniQure To Present At NewsMakers In The Biotech Industry Conference - NYC
2015-08-27,UniQure Announces Financial Results For Second Quarter 2015
2015-08-10,UniQure Announces Receipt Of $53 Million From Bristol-Myers Squibb For Target Selection Payment And Additional Equity Investment
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-07-16,Dr. Charles W. Richard Joins UniQure As Senior Vice President To Lead Development Of CNS-focused Gene Therapy Pipeline
2015-06-13,Bluebird Sickle Cell Gene Therapy Results Keep Getting Better
2015-06-11,UniQure Announces Financial Results For First Quarter 2015
2015-05-27,UniQure To Present At The Jefferies 2015 Healthcare Conference
2015-05-26,UniQure Announces Closing Of Strategic Collaboration With Bristol-Myers Squibb To Develop Gene Therapies For Cardiovascular Disease
2015-05-21,Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease
2015-05-12,Ratings Changes Today
2015-04-26,Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
2015-04-15,UniQure Announces Closing Of Follow-on Public Offering
2015-04-09,UniQure Announces Pricing Of Follow-on Public Offering
2015-04-07,UniQure Announces Launch Of Follow-on Public Offering
2015-04-06,Market News: Tesla Motors Inc, Uniqure NV, Transocean LTD
2015-04-06,Stocks Spike on Fed Rate Hike Speculation; Microsoft Leads Dow
2015-04-06,Stocks Drive Higher as Energy Rally Overshadows Weak Jobs Report
2015-04-06,UniQure NV (QURE) Stock Soars to 52-Week High on Bristol-Myers Squibb Investment
2015-04-06,UniQure Announces Webcast To Discuss Bristol-Myers Squibb Collaboration
2015-04-06,UniQure Announces Results For Fourth Quarter And Financial Year 2014
2015-04-06,Bristol-Myers Squibb And UniQure Enter Into Exclusive Strategic Collaboration To Develop Gene Therapies For Cardiovascular Diseases
2015-02-23,UniQure To Present At The At The Cowen And Company 35th Annual Health Care Conference
2015-02-06,UniQure To Present At The At The Leerink Partners Global Healthcare Conference
2015-01-15,Gold Surge Spells Good Things For Soros, Dalio
2015-01-14,Treeway Announces License And Collaboration Agreement With UniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS)
2015-01-09,UniQure Appoints Matthew Kapusta As Chief Financial Officer
2015-01-05,Ackman Short Keeps Looking Better As Herbalife Takes A Dive
2014-12-05,UniQure To Present At The Oppenheimer 25th Healthcare Conference - NYC
2014-12-01,UniQure Announces Results For The Third Quarter Of 2014
2014-11-21,UniQure To Host Investor Day In New York City
2014-11-10,UniQure To Present At Jefferies Global Healthcare Conference - London
2014-10-27,AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data From Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate
2014-09-25,UniQure To Present At The Leerink Partners Rare Disease Roundtable Conference
2014-09-02,UniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs
2014-08-11,UniQure Acquires Cardiology Gene Therapy Company InoCard
2014-08-04,Chiesi And UniQure Provide Update On Glybera(r) Launch
2014-04-28,3 Stocks Rising on Big Volume
,
,
2017-03-15,UniQure Announces 2016 Financial Results And Provides Update On Company Progress
2017-03-03,UniQure Receives 2017 Frost & Sullivan Manufacturing Leadership Award
2017-03-01,UniQure Announces Presentations At Upcoming March Conferences
2017-02-06,UniQure Announces Presentations At Upcoming February Conferences
2017-01-30,UniQure Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B
2017-01-25,UniQure Appoints Alexander Kuta As Senior Vice President Of Regulatory Affairs
2017-01-09,UniQure Outlines Key Initiatives For 2017 And Vision For 2018
2017-01-06,5 Stocks Setting Up for Big Breakouts
2016-12-19,UniQure Appoints Matthew Kapusta As Chief Executive Officer
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-03,UniQure Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B
2016-12-03,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
2016-12-02,UniQure To Present At The Genetic Rx Boston Biotech Conference At Harvard Medical School
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-22,UniQure Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress
2016-11-15,UniQure Completes Strategic Review To Refocus Its Pipeline, Reduce Operating Costs And Deliver Long-Term Shareholder Value
2016-09-26,UniQure To Present At The Jefferies Gene Editing And Gene Therapy Summit In New York City
2016-09-22,UniQure Announces Management And Board Changes
2016-09-16,UniQure Receives NASDAQ Deficiency Letter Related To Board Composition
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-25,UniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
2016-08-17,UniQure To Present At Upcoming Investor Conferences In September
2016-07-29,8 Stocks Under $10 to Trade for Huge Profits
2016-07-27,UniQure Presents Updated Clinical Data In Patients With Severe Hemophilia B Demonstrating Up To 9 Months Of Sustained Levels Of Factor IX Activity And Therapeutic Effect
2016-07-11,UniQure Announces Oral Presentation Of Updated Results For AMT-060 At The World Federation Of Hemophilia (WFH) 2016 World Congress
2016-07-07,UniQure Appoints Jonathan Garen As Chief Business Officer
2016-07-01,These 5 Stocks Are Ready for Breakouts
2016-06-27,UniQure Appoints Maria E. Cantor As Senior Vice President, Investor Relations & Communications
2016-06-14,Trade-Ideas: UniQure (QURE) Is Today's Weak On High Relative Volume Stock
2016-06-11,UniQure Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity
2016-05-31,UniQure Announces Results For First Quarter 2016
2016-05-19,UniQure Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association
2016-05-12,UniQure To Present At Upcoming Investor Conferences In New York City
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
2016-05-09,UniQure Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT
2016-05-03,UniQure Appoints Paul Firuta As Chief Commercial Officer
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-19,UniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
2016-04-04,CORRECTING And REPLACING -- UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-04-04,UniQure Announces Results For Fourth Quarter And Financial Year 2015
2016-03-24,Interesting QURE Put And Call Options For May 20th
2016-03-22,UniQure Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease
2016-03-14,UniQure Announces Dosing Of First Patient In High-Dose Cohort In Phase I/II Hemophilia B Clinical Trial
2016-03-02,UniQure To Present At The 36th Cowen & Company Health Care Conference
2016-02-15,UniQure To Present At The RBC Capital Markets 2016 Global Healthcare Conference
2016-01-28,'Mad Money' Lightning Round: Take the Money and Run From Sprint
2016-01-27,Jim Cramer's 'Mad Money' Recap: More Pain Ahead, Thanks to the Fed
2016-01-11,UniQure (QURE) Weak On High Volume Today
2016-01-08,Buy These 5 Breakout Stocks Now for Big Gains
2016-01-07,UniQure Announces Preliminary Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2016-01-06,UniQure Announces Conference Call And Webcast To Discuss Topline Results From Low-Dose Cohort In Hemophilia B Phase I/II Gene Therapy Clinical Trial
2015-12-18,UniQure Appoints Dan Soland As Chief Executive Officer
2015-12-14,UniQure Added To NASDAQ Biotechnology Index
2015-11-30,UniQure (QURE) Weak On High Volume Today
2015-11-30,UniQure Announces Financial Results For Third Quarter 2015 And Provides Update On Product Pipeline And Company Developments
2015-11-23,UniQure Announces Conference Call And Webcast To Discuss Third Quarter Financial Results And Corporate Update
2015-11-12,UniQure To Present At The Jefferies 2015 Global Healthcare Conference - London
2015-11-06,Interesting QURE Put And Call Options For November 20th
2015-10-07,UniQure To Host Investor Day In New York City On October 15, 2015
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-09-30,UniQure (QURE) Marked As A Dead Cat Bounce Stock
2015-09-22,Today's Dead Cat Bounce Stock: UniQure (QURE)
2015-09-21,UniQure (QURE) Trading With Heavy Volume Before Market Open
2015-09-19,Positive Topline Results Announced From Phase I/II Trial In Sanfilippo B Syndrome Patients Using UniQure's Novel AAV5-Based Gene Therapy
2015-09-18,UniQure (QURE) Is Today's Strong On High Volume Stock
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-01,UniQure To Present At NewsMakers In The Biotech Industry Conference - NYC
2015-08-27,UniQure Announces Financial Results For Second Quarter 2015
2015-08-10,UniQure Announces Receipt Of $53 Million From Bristol-Myers Squibb For Target Selection Payment And Additional Equity Investment
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-07-16,Dr. Charles W. Richard Joins UniQure As Senior Vice President To Lead Development Of CNS-focused Gene Therapy Pipeline
2015-06-13,Bluebird Sickle Cell Gene Therapy Results Keep Getting Better
2015-06-11,UniQure Announces Financial Results For First Quarter 2015
2015-05-27,UniQure To Present At The Jefferies 2015 Healthcare Conference
2015-05-26,UniQure Announces Closing Of Strategic Collaboration With Bristol-Myers Squibb To Develop Gene Therapies For Cardiovascular Disease
2015-05-21,Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease
2015-05-12,Ratings Changes Today
2015-04-26,Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
2015-04-15,UniQure Announces Closing Of Follow-on Public Offering
2015-04-09,UniQure Announces Pricing Of Follow-on Public Offering
2015-04-07,UniQure Announces Launch Of Follow-on Public Offering
2015-04-06,Market News: Tesla Motors Inc, Uniqure NV, Transocean LTD
2015-04-06,Stocks Spike on Fed Rate Hike Speculation; Microsoft Leads Dow
2015-04-06,Stocks Drive Higher as Energy Rally Overshadows Weak Jobs Report
2015-04-06,UniQure NV (QURE) Stock Soars to 52-Week High on Bristol-Myers Squibb Investment
2015-04-06,UniQure Announces Webcast To Discuss Bristol-Myers Squibb Collaboration
2015-04-06,UniQure Announces Results For Fourth Quarter And Financial Year 2014
2015-04-06,Bristol-Myers Squibb And UniQure Enter Into Exclusive Strategic Collaboration To Develop Gene Therapies For Cardiovascular Diseases
2015-02-23,UniQure To Present At The At The Cowen And Company 35th Annual Health Care Conference
2015-02-06,UniQure To Present At The At The Leerink Partners Global Healthcare Conference
2015-01-15,Gold Surge Spells Good Things For Soros, Dalio
2015-01-14,Treeway Announces License And Collaboration Agreement With UniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS)
2015-01-09,UniQure Appoints Matthew Kapusta As Chief Financial Officer
2015-01-05,Ackman Short Keeps Looking Better As Herbalife Takes A Dive
2014-12-05,UniQure To Present At The Oppenheimer 25th Healthcare Conference - NYC
2014-12-01,UniQure Announces Results For The Third Quarter Of 2014
2014-11-21,UniQure To Host Investor Day In New York City
2014-11-10,UniQure To Present At Jefferies Global Healthcare Conference - London
2014-10-27,AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data From Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate
2014-09-25,UniQure To Present At The Leerink Partners Rare Disease Roundtable Conference
2014-09-02,UniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs
2014-08-11,UniQure Acquires Cardiology Gene Therapy Company InoCard
2014-08-04,Chiesi And UniQure Provide Update On Glybera(r) Launch
2014-04-28,3 Stocks Rising on Big Volume
,
,
